🇺🇸 FDA
Pipeline program

BEAM-103

BTX-103-001

Phase 1 small_molecule active

Quick answer

BEAM-103 for Healthy Subjects is a Phase 1 program (small_molecule) at Beam Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Beam Therapeutics
Indication
Healthy Subjects
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials